558 related articles for article (PubMed ID: 27742105)
1. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.
Sala E; Mema E; Himoto Y; Veeraraghavan H; Brenton JD; Snyder A; Weigelt B; Vargas HA
Clin Radiol; 2017 Jan; 72(1):3-10. PubMed ID: 27742105
[TBL] [Abstract][Full Text] [Related]
2. Editorial.
Baxter G
Clin Radiol; 2017 Jan; 72(1):1-2. PubMed ID: 27836105
[No Abstract] [Full Text] [Related]
3. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
Elshafeey N; Hassan I; Zinn PO; Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
[TBL] [Abstract][Full Text] [Related]
4. A review of radiomics and genomics applications in cancers: the way towards precision medicine.
Li S; Zhou B
Radiat Oncol; 2022 Dec; 17(1):217. PubMed ID: 36585716
[TBL] [Abstract][Full Text] [Related]
5. Radiogenomics: a key component of precision cancer medicine.
Liu Z; Duan T; Zhang Y; Weng S; Xu H; Ren Y; Zhang Z; Han X
Br J Cancer; 2023 Sep; 129(5):741-753. PubMed ID: 37414827
[TBL] [Abstract][Full Text] [Related]
6. Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.
Pinker K; Chin J; Melsaether AN; Morris EA; Moy L
Radiology; 2018 Jun; 287(3):732-747. PubMed ID: 29782246
[TBL] [Abstract][Full Text] [Related]
7. Radiogenomics: what it is and why it is important.
Mazurowski MA
J Am Coll Radiol; 2015 Aug; 12(8):862-6. PubMed ID: 26250979
[TBL] [Abstract][Full Text] [Related]
8. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images.
Abrol S; Kotrotsou A; Salem A; Zinn PO; Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):43-53. PubMed ID: 28079714
[TBL] [Abstract][Full Text] [Related]
9. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).
Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
Mol Diagn Ther; 2019 Feb; 23(1):27-51. PubMed ID: 30387041
[TBL] [Abstract][Full Text] [Related]
10. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).
Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
Mol Diagn Ther; 2019 Feb; 23(1):1-26. PubMed ID: 30411216
[TBL] [Abstract][Full Text] [Related]
11. Radiogenomics: bridging imaging and genomics.
Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer: An update on imaging in the era of radiomics.
Nougaret S; Tardieu M; Vargas HA; Reinhold C; Vande Perre S; Bonanno N; Sala E; Thomassin-Naggara I
Diagn Interv Imaging; 2019 Oct; 100(10):647-655. PubMed ID: 30555018
[TBL] [Abstract][Full Text] [Related]
13. The application of radiomics in predicting gene mutations in cancer.
Qi Y; Zhao T; Han M
Eur Radiol; 2022 Jun; 32(6):4014-4024. PubMed ID: 35048135
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI radiogenomics: Current status and research implications.
Grimm LJ
J Magn Reson Imaging; 2016 Jun; 43(6):1269-78. PubMed ID: 26663695
[TBL] [Abstract][Full Text] [Related]
15. Towards precision medicine: from quantitative imaging to radiomics.
Acharya UR; Hagiwara Y; Sudarshan VK; Chan WY; Ng KH
J Zhejiang Univ Sci B; 2018 Jan.; 19(1):6-24. PubMed ID: 29308604
[TBL] [Abstract][Full Text] [Related]
16. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.
Chowdhury R; Ganeshan B; Irshad S; Lawler K; Eisenblätter M; Milewicz H; Rodriguez-Justo M; Miles K; Ellis P; Groves A; Punwani S; Ng T
Br J Radiol; 2014 Jun; 87(1038):20140065. PubMed ID: 24597512
[TBL] [Abstract][Full Text] [Related]
17. MRI Radiogenomics in Precision Oncology: New Diagnosis and Treatment Method.
Yin XX; Gao M; Wang W; Zhang Y
Comput Intell Neurosci; 2022; 2022():2703350. PubMed ID: 35845886
[TBL] [Abstract][Full Text] [Related]
18. "Radio-oncomics" : The potential of radiomics in radiation oncology.
Peeken JC; Nüsslin F; Combs SE
Strahlenther Onkol; 2017 Oct; 193(10):767-779. PubMed ID: 28687979
[TBL] [Abstract][Full Text] [Related]
19. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
20. Implications of intratumour heterogeneity for treatment stratification.
Crockford A; Jamal-Hanjani M; Hicks J; Swanton C
J Pathol; 2014 Jan; 232(2):264-73. PubMed ID: 24115146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
